Epigenetic Regulators Involved in Cancer

Wednesday, 5 September 2012 at 15:45

Add to Calendar ▼2012-09-05 15:45:002012-09-05 16:45:00Europe/LondonEpigenetic Regulators Involved in CancerSELECTBIOenquiries@selectbiosciences.com

Misregulation of epigenetic regulators underpins the molecular pathogenesis of several haematological malignancies. Therefore, understanding the molecular mechanisms by which these chromatin regulators contribute to cancer will provide a unique opportunity to target these factors with novel epigenetic therapies.

Mark Dawson, Wellcome Trust Beit Fellow and Haematology Consultant, University of Cambridge

Mark Dawson

Mark Dawson is a Clinician-Scientist at the Department of Haematology, University of Cambridge whose research interest is chromatin regulation in the haematological malignancies. He is a Fellow of the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia. After completing his clinical training in 2006 he was awarded the prestigious General Sir John Monash Fellowship and Cambridge Commonwealth Trust Fellowship, which he used to complete his PhD at the University of Cambridge. In 2009 he was awarded the inaugural Wellcome Trust Beit Prize Fellowship to pursue his research into chromatin regulation of leukaemia stem cells. He currently holds a joint position at the Gurdon Institute and Cambridge Institute for Medical research and is a consultant haematologist at Addenbrooke’s Hospital.